Internal Med Medical News about Colitis, Ulcerative

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
Inflammatory Bowel Disease, 11/04/09

Lukas M et al. – In the uncontrolled trial, administration of exogenous AP enzyme daily over a 7–day course to patients with UC was associated with short–term improvement in disease activity scores, with clinical effects being observed within 21 days and associated with reductions in C–reactive protein and stool calprotectin. AP enzyme treatment was well tolerated and nonimmunogenic.